American Seed & Oil Company Announces Medical Cannabis Cooperative For Independent Hemp And Marijuana Cultivators
Hemp and Marijuana Cultivators To Benefit From Cooperative Funding, Improved Buying Power And Product Branding
Dallas, TX / April 7, 2015 / Algae International Group, Inc. (OTC: ALGA), through its operating subsidiary American Seed & Oil Company, today Announced The American Seed & Oil Company Medical Cannabis Cooperative. The intent of the Cooperative is to build an organization of independent hemp and marijuana cultivation organizations that by working together can more rapidly and soundly expand their respective operations. American Seed & Oil Company is dedicating its previously announced $1.2 million in secured funding to The Medical Cannabis Cooperative.
“American Seed & Oil Company is committed to establishing a leadership position within the developing U.S. legal cannabis industry,” said Steven Rash, CEO of Algae International, Inc. and its operating subsidiary, the American Seed & Oil Company. “We believe our investment of time, talent and resources in a Cooperative Cannabis Cultivation strategy will more rapidly expand our revenues and assets than solely investing in the construction of wholly owned cannabis cultivation operations.”
Mr. Rash goes on to explain the origin and purpose of the Cooperative:
“We are already piloting a number of cannabis consumer products; working to develop a number of cannabis commercial products; contributing to the effort to mature and advance legalization nationwide and at the same time investing in the infrastructure to grow and process cannabis. We continue to evaluate and evolve our overall approach toward all these ends. In so doing, we are launching a Medical Cannabis Cooperative in order to partner with knowledgeable growers that see the benefit as we do in establishing a mutually beneficial set of business and product standards for the cultivation of therapeutic hemp and marijuana. Cooperative participants will agree to, codify and follow cultivation and business standards that help to legitimize the industry and advance the legalization process."
Mr. Rash highlights the anticipated benefits to Cooperative participants:
“As a Cooperative, the participants stand to benefit from improved buying power and access to commercial and investment banking. By agreeing to high cultivation standards, the participants can establish a collective brand recognize for ‘high quality’ and position their products at a premium in the market place. Furthermore, the collective voice of a Cooperative is more likely to influence the various legislative bodies toward action that accelerates legalization momentum.“
Mr. Rash describes the American Seed & Oil Company role within the Cooperative:
“American Seed & Oil has won the support of the private investor that committed $1.2 million in funding to build wholly owned marijuana grow rooms to now support the American Seed & Oil Medical Cannabis Cooperative and we plan to source additional investment to fund further Cooperative expansion overtime. We look forward to hearing from hemp and marijuana growers interested in participating in the American Seed & Oil Medical Cannabis Cooperative and bringing the initial $1.2 million investment to bear in a collective expansion of the participants existing operations.”
About Algae International Group, Inc.
Algae International Group, Inc. (ALGA), through its operating subsidiary American Seed & Oil Company, Inc., is in the business of hemp production to supply seed to the expanding hemp farming market and hemp based consumer and commercial product markets. The Company is also piloting a number of other cannabis related consumer and commercial products and service offerings as part of a comprehensive strategy to stimulate a rapid expansion of the growing market place for legal cannabis. For more information please visitwww.americanseedandoil.com
Follow the company on Twitter: http://twitter.com/US_HEMP
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.